Trial NCT04612725

View at ClinicalTrials.gov 
Org. Study IDs: D3259C00001
Secondary IDs: 2020-000169-17

Last trial update was posted on 2024-03-13

MeSH Interventions

Benralizumab

MeSH Conditions

Chronic Urticaria Urticaria

Other Conditions

Chronic Spontaneous Urticaria

Stopping Reasons

Study did not meet primary endpoint

Limitations And Caveats

The study was terminated early by the sponsor as the primary analysis results did not support the continued development of benralizumab for the indication of CSU.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID